Milos Miljkovic

Company: Cartesian Therapeutics

Job title: Chief Medical Officer

Seminars:

Pioneering RNA Cell Therapy for Autoimmune Diseases 11:00 am

Developing the first RNA cell therapy in an autoimmune disease, Descartes-08 Sharing long-term follow-up data from the phase 1/2a open-label trial in patients with myasthenia gravis Discussing the next steps for Descartes-08 in myasthenia gravis and other autoimmune indicationsRead more

day: Conference Day Two